Write For Us

"CoWIN Best Vaccination Application In The World": Dr RS Sharma | Left, Right & Centre

Sponsored Post Vitamin D2 Canada Persia
60 Views
Published
After a revised UK advisory accepted Covishield as a valid vaccine but said double-jabbed Indians still have to quarantine because of 'vaccination certification issues', Dr RS Sharma, National Health Authority CEO & Head of the Cowin App, tells NDTV "UK is interested in knowing the CoWIN architecture. Our technical team has interacted with the UK technical team. Two meetings have taken place and during those discussions, there were absolutely no concerns raised. CoWIN is one of the best applications in the vaccination area in the whole world, it is a fact. The entire process is digital, what comes out is a digital certificate that can be verified for its authenticity, integrity and truth. We have been very aligned and conscious of the fact that digital certificates will be needed, so the entire process from Day 1 has been completely digital."

About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe to our channels:
NDTV: https://www.youtube.com/user/ndtv?sub_confirmation=1
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindia?sub_confirmation=1

Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Koo: https://www.kooapp.com/profile/ndtv
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps:
http://www.ndtv.com/page/apps

Watch More Videos:
http://www.ndtv.com/video?yt

#LeftRightCentre
Category
Asia
Tags
NDTV 24x7, RS Sharma, UK Vaccine Row
Sign in or sign up to post comments.
Be the first to comment